Holst JJ - Search Results

1

Short-term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: A randomized open-label crossover trial.

Ranjan A, Schmidt S, Damm-Frydenberg C, Holst JJ, Madsbad S, Nørgaard K. Ranjan A, et al. Among authors: holst jj. Diabetes Obes Metab. 2017 Oct;19(10):1479-1484. doi: 10.1111/dom.12953. Epub 2017 Jul 10. Diabetes Obes Metab. 2017. PMID: 28345762 Clinical Trial.

2

Short time effects of growth hormone on glucose metabolism and insulin and glucagon secretion in normal man.

Busch-Sørensen M, Holst JJ, Lyngsøe J. Busch-Sørensen M, et al. Among authors: holst jj. J Endocrinol Invest. 1991 Jan;14(1):25-30. doi: 10.1007/BF03350253. J Endocrinol Invest. 1991. PMID: 1675225 Clinical Trial.

3

Glucagon immunoneutralization in diabetic rats normalizes urea synthesis and decreases nitrogen wasting.

Almdal TP, Holst JJ, Heindorff H, Vilstrup H. Almdal TP, et al. Among authors: holst jj. Diabetes. 1992 Jan;41(1):12-6. doi: 10.2337/diab.41.1.12. Diabetes. 1992. PMID: 1727732

4

All products of proglucagon are elevated in plasma from uremic patients.

Orskov C, Andreasen J, Holst JJ. Orskov C, et al. Among authors: holst jj. J Clin Endocrinol Metab. 1992 Feb;74(2):379-84. doi: 10.1210/jcem.74.2.1730817. J Clin Endocrinol Metab. 1992. PMID: 1730817

5

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine.

Orskov C, Jeppesen J, Madsbad S, Holst JJ. Orskov C, et al. Among authors: holst jj. J Clin Invest. 1991 Feb;87(2):415-23. doi: 10.1172/JCI115012. J Clin Invest. 1991. PMID: 1991827 Free PMC article.

6

Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects.

Deacon CF, Nauck MA, Toft-Nielsen M, Pridal L, Willms B, Holst JJ. Deacon CF, et al. Among authors: holst jj. Diabetes. 1995 Sep;44(9):1126-31. doi: 10.2337/diab.44.9.1126. Diabetes. 1995. PMID: 7657039

7

Glucagonlike peptide 1: a newly discovered gastrointestinal hormone.

Holst JJ. Holst JJ. Gastroenterology. 1994 Dec;107(6):1848-55. doi: 10.1016/0016-5085(94)90831-1. Gastroenterology. 1994. PMID: 7958701 Review.

8

Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM.

Gutniak MK, Linde B, Holst JJ, Efendić S. Gutniak MK, et al. Among authors: holst jj. Diabetes Care. 1994 Sep;17(9):1039-44. doi: 10.2337/diacare.17.9.1039. Diabetes Care. 1994. PMID: 7988303 Clinical Trial.

9

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.

Orskov C, Rabenhøj L, Wettergren A, Kofod H, Holst JJ. Orskov C, et al. Among authors: holst jj. Diabetes. 1994 Apr;43(4):535-9. doi: 10.2337/diab.43.4.535. Diabetes. 1994. PMID: 8138058

10

Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man.

Hvidberg A, Nielsen MT, Hilsted J, Orskov C, Holst JJ. Hvidberg A, et al. Among authors: holst jj. Metabolism. 1994 Jan;43(1):104-8. doi: 10.1016/0026-0495(94)90164-3. Metabolism. 1994. PMID: 8289665

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results